| Chr | chr2 |
| start | 27392784 |
| end | 27393367 |
| lncRNA name | FTH1P3 |
| entrez id | NA |
| hgnc id | NA |
| ensg id | ENSG00000213453 |
| refseq id | NA |
| methods | qPCR,Flow cytometry assay,Western blot,Luciferase reporter assay,etc. |
| regulated | up-regulated |
| function description | Bioinformatics tools and luciferase reporter assay validated that,FTH1P3 promoted ABCB1 protein expression through targeting miR-206,acting as,a miRNA sponge. In summary,our results reveal the potential regulatory mechanism ,of FTH1P3 on breast cancer paclitaxel resistance through miR-206/ABCB1,providing a novel insight for the breast cancer chemoresistance. However,the occurrence of chemoresistance causes the poor prognosis,high recurrence rate and low 5-year survival rate.In the present study,we investigate the role of lncRNA FTH1P3 in breast cancer paclitaxel resistance and explore the underlying mechanism for the drug resistance generation. |
| pubmed id | 29971911 |
| year | 2018 |
| title | Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1. |
| drug | V |
| circulating | X |
| survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China